Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


Biologics valuable treatment option for patients with inflammatory bowel disease

, the official journal of the American Gastroenterological Association (AGA) Institute. IBD includes Cro...

FDA Nanotechnology Task Force takes positive step forward

The Task Force is clear and candid in acknowledging the pervasive potential of nanotechnology to affect virtually every product category FDA regulates—from p...

A new century of Alzheimer's disease research

...

Support for Children's Health and Medicare Protection Act given to House leaders by ACP

Washington -- In a letter to leaders of the U.S. House of Representatives Ways and Means, and Energy and Commerce committees, the president of the American College of Physicians (ACP) today expressed support for the Children’s Health and Medicare Preotection (CHAMP) Act of 2007 (H.R. 3162). Representing 124,000 internal medicine physicians and medical student members, ACP is the largest medica...

White Blood Cell Booster May Help Cancer Patients Avoid Deadly Complications

DURHAM, N.C. -- Cancer patients who receive a drug that stimulates the growth of infection-fighting white blood cells may be significantly less likely to die from a chemotherapy-related complication characterized by fever and low white blood cell levels, according to a multi-institutional study led by researchers from the University of Rochester School of Medicine and Dentistry and the <A href...

Advanced therapy offers cure for relapsed cancer patient

About 90 percent of testicular cancer patients respond to traditional therapy, which involves multiple courses...

Researchers Discover How Cancer Evades the Immune System

A study on various kinds of cancer, conducted by researchers at the University of Southern California, has brought about the discovery of a new method to identify the genetic changes that enable tumours to evade the body's immune system. The findings, demonstrated in human breast and colorectal cancers, are significant to the field of medicine because they may lead to the advancem...

Structure of TB Enzyme Points the Way to New Drugs: Study

Swiss scientists said Monday that they have further evidence to suggest that an enzyme secreted by the microbe that causes tuberculosis would make a promising target for new drugs to combat the deadly infectious disease. The Swiss team first identified the enzyme, protein kinase G (PknG), as a promising drug target back in 2004. At the time, they said that the protein...

Singapore Dengue Cases Return to Epidemic Level

Dengue cases in affluent Singapore have reached 'epidemic' levels for the second time in the past month, health ministry data monitored Tuesday said. The Ministry of Health said 381 cases were reported between June 24 and 30, above the 'epidemic threshold' of 378 cases per week. Dengue cases crossed the threshold for the first time since 2005 earlier in June, when 401...

UN Calls for Pedal Power to Reduce Environmental Damage

More bicycle riding and other lifestyle changes are urgently needed to reduce climate-altering carbon emissions that are damaging Asia's health and could also threaten the economy, the World Health Organisation said Monday. Climate change contributes directly or indirectly to about 77,000 deaths per year in the region, according to WHO estimates. "So far the impact is...
[next]
(Date:5/13/2008)... HARBIN, China, May 13 /Xinhua-PRNewswire-FirstCa...oard: CSKI), a manufacturer, marketer and,distribu...oducts in China,today announced that it will cond... May 15, 2008 to discuss its first quarter 2008 fi...man, CEO and Director of China Sky One,Medical, In...
(Date:5/13/2008)...ildbearing had no such benefit if baby was bottle-...13 (HealthDay News) -- Women who breast feed for m...arthritis (RA) by half, according to a new Swedish...g children but not breast-feeding offered women no...contraceptives also failed to reduce the risk of R...
(Date:5/13/2008)...NEW YORK (May 13, 2008) -- Promising results from ...ell Medical Center physician-scientists show that ... the progression of Batten disease, or Late Infant..., genetic, degenerative neurological disorder that... to 12. , The clinical trial found that the pro...
(Date:5/13/2008)... SALT LAKE CITY, May 13 /PRNewswire/ -- Paramed S...ent of their marine-grade Mobility Offers,Versatil...chair to oil and,gas platform operators in the Gul...platforms will enable the safe and timely evacuati...atform., Paramed developed the dual-track MOV in ...
Breaking Medicine News(10 mins):Health News:China Sky One Medical, Inc. Announces Conference Call to Discuss First Quarter 2008 Results 2Health News:Breast-feeding Might Shield Women From Rheumatoid Arthritis 2Health News:NYP/Weill Cornell gene therapy clinical trial yields promising results for Batten disease 2
...ltinational team of researchers based in the UK ha...s biological barriers, opening up the potential fo...rchers from the School of Pharmacy, University of ...otubes by adding a range of different functional g...
...U.S. Food and Drug Administration (FDA) today clea... device that can help save the arms and legs of so...ndividuals in other trauma settings and emergency ... Limb Salvage Shunt (TLSS), made by Vascutek Ltd. ...
...a's drug major Ranbaxy Laboratories has received t...pproval to manufacture// and market its formulatio...in adults. Ranbaxy Pharmaceuticals Inc. (RPI), a ...oratories Limited (RLL), announced Friday that FDA...
...he recent years, scientists discovered a family of...xtend life in organisms// as diverse as yeast, wor...t The Wistar Institute points to another strategy ...ir anti-aging powers. They may also be able to con...
Other Medicine News:Health News:Carbon Nanoneedles For Drug Delivery 2Health News:Carbon Nanoneedles For Drug Delivery 3Health News:Carbon Nanoneedles For Drug Delivery 4Health News:FDA Clears Critical Limb-Saving Vascular Device 2Health News:Anti-Aging Powers of Enzyme Sirtuins 2
VG2 PLIF Allograft is comprised of two cortical planks of bone surrounding a cancellous center. The cortical planks provide strength for anterior column support. The cancellous bone provides a lattic
Williams Micro Discectomy Instruments are designed to be used in the microsurgical treatment of herniated disks.
Meyerding Laminectomy Retractors, self-retaining.
Karlin Crank Frame Spinal Retractor Set is designed for posterior lumbar and thoracic spine surgery. Arm design allows the blades be pre-positioned in the wound prior to attachment.
Medicine Products:
(Date:5/12/2008)...Patients in Cohort 3 Demonstrated Improvement in T...rapeutic Potential of HspE7, SAN DIEGO, May 12 /P...Corporation (TSX: NVN) today announced positive im...ing Phase 1 clinical trial of its lead product,can...helial neoplasia, or,CIN, a precursor to cervical ...
(Date:5/9/2008)...A, Fla., May 9 /PRNewswire-USNewswire/ -- Osteoart...ondition that affects almost 50,million people in ...f,cartilage in bone joints. The novel investigatio... oral analgesic, provided significant relief,for p... treated with,placebo, and with fewer gastrointest...
(Date:5/9/2008)...TTLE, May 9 /PRNewswire-USNewswire/ -- The risk of...n prostatic hyperplasia (BPH), can be,reduced by c...ntaining a,normal weight and eating a healthy diet...cer Prevention Program at Fred Hutchinson Cancer R...ies that suggest men need not,feel helpless agains...
(Date:5/9/2008)...th International Phase III Study Shows Positive Re...ata -, NUTLEY, N.J., May 9 /- Roche ...ar Phase III study showing that ACTEMRA(TM),(tocil...tructural damage to,joints in patients with rheuma...veness of an RA treatment. The study also demonstr...
Breaking Medicine Technology:Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 2Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 3Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 4Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 5Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 6Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 2Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 3Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 4Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 5Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Men's Health Week Is June 9-15) 2Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Men's Health Week Is June 9-15) 3Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Men's Health Week Is June 9-15) 4New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 2New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 3New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 4New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 5Memory in artificial atoms 4445 1Memory in artificial atoms 4445 2Faster Test Detects Fake Tamiflu Drugs 16192 1Faster Test Detects Fake Tamiflu Drugs 16192 2Chehalis Tribes Announce Benefit to Help Returning Combat Veterans 16187 1Chehalis Tribes Announce Benefit to Help Returning Combat Veterans 16187 2Genaera Corporation Receives Audit Opinion Containing Going Concern Explanatory Paragraph 16183 1Genaera Corporation Receives Audit Opinion Containing Going Concern Explanatory Paragraph 16183 2Genaera Corporation Receives Audit Opinion Containing Going Concern Explanatory Paragraph 16183 3
... Vaginal Supplement Studied in Largest-Ever IVF Tr...PRNewswire/ -- Results of,four studies evaluating ...ogesterone vaginal insert in development for lutea...t for implantation and,the early stages of pregnan...re presented at the 55th Annual Meeting of the,Pac...
... N.J., April 18, 2007 /PRNewswire-FirstCall/ --,ON...rug candidate,may have potential as a chemopreven...ma researcher Michele Carbone M.D., Ph.D.,at this...AACR),Annual Meeting. , In a series of poster pres...ldwide problem of asbestos exposure and its link t...
Other Medicine Technology:Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 2Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 3Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 4Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 5Onconase has Potential as Chemopreventive Agent in Mesothelioma,Reports World-Renowned Mesothelioma Researcher at AACR Annual,Meeting 2Onconase has Potential as Chemopreventive Agent in Mesothelioma,Reports World-Renowned Mesothelioma Researcher at AACR Annual,Meeting 3Onconase has Potential as Chemopreventive Agent in Mesothelioma,Reports World-Renowned Mesothelioma Researcher at AACR Annual,Meeting 4